Daily as of 3 Nov 16:00 ET
- Price
- below both $14.94 vs 50 $20.16 / 200 $20.96
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 9 Jan 2026 · not projected
AKTS | Aktis OncologyNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$14.94
+$0.35 (+2.40%)
Aktis Oncology (AKTS) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $15.93 vs 50 $18.08 / 200 $6.38
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 16 Mar 2026 · projected 10 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- below both $14.94 vs 50 $16.78 / 200 $22.76
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 30 Sep 2026 · projected 26 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 30 Sep 2026 | 💀Death | 4-hour | 26 bars out | Not tested |
| week of 16 Mar 2026 | 🟨Golden steep | weekly | 10 bars out | — |
| 9 Jan 2026 | 🟨Golden | daily | not projected | — |
| 28 Mar 2023 | 💀Death | daily | 6 bars out | Not tested |
| 17 Mar 2023 | 🟨Golden | daily | 19 bars out | Not tested |
About AKTS
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$5.6M
4-hour coverageYes, since Jan 2026
History on recordSince 2018
SectorHealthcare
Cap bandsmall